- Originated and advised private equity sponsors on articulating healthcare services investment thesis & platform roll-out strategy based on insights from deep market and opportunity analytics that resulted in investment allocation of US $250M++

- Led roll-out out of 4 significant US focused healthcare services platforms in dermatology, integrated women’s health, behavioral health, and home health - US $600M+ deal pipeline

- Spearheaded several institutionalization initiatives

Originated and managed US $350+mn in complex mergers and acquisitions, leveraged buy-out, and structured finance transactions in less than 9 months since joining; including strategizing and leading a game-changing consumer buy-out deal (US $275M+) as a platform for a mega roll-up play

Utilized predictive analytics and prescriptive analytics to convince investors and business owners/CXOs to build-out game-changing platforms in consumer and healthcare

Successfully advised business founders and world-class investors by leveraging regression based models to establish US $100mn platform for doing a roll-up play in specialty healthcare clinics in the infertility space

Utilized financial analytics to articulate and get buy-in from shareholders to commit US $20mn in corner-stone investment for establishing a US $300mn deep value investment fund

Ramped up deal pipeline from $10M to $750M in prime lower to mid-market transactions

Designed innovative integrated value-driver and financial analytics enabled marketing strategy that resulted in access to over US$ 1.5B in prime mid-market deals in the infrastructure, manufacturing, and healthcare

Utilized predictive market structure analytics for a Royal Family office to acquire a US$ 110mn State owned Oil & Gas asset as a corporate carve-out

Advised a Qatar based Investments Co. (high profile institutional and UHNW Royal Family shareholders) with a US$ 300mn deal pipeline on a potential joint-venture with a leading Russian investment firm

Capital raising, valuation, and investment structuring for a US$ 1.3B private placement of a strategic India-China emerging 4G mobile venture